Back to News
Market Impact: 0.15
Cybin Inc. Announces Co-Founders' Transition from Executive Leadership on October 27, 2026
Source: Nasdaq
Management & Governance
Helus Pharma Inc. (formerly Cybin Inc.) filed a Form 6-K on October 27, 2026, incorporating a news release about executive leadership transitions. Co-founders Eric So and Paul Glavine have stepped down from their respective roles; the provided excerpt is truncated before specifying the roles or further details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- The big takeaways and big questions from Anthropic’s S-1
- Tech's relief rally extends as attention turns to tough decisions for the Fed
- UPS Raises Outlook as CEO Plans to Stay On to Oversee Union Talks
- Walmart says AI training is boosting confidence with the technology among its 2.1 million associates
- HSBC reports third-quarter pretax profit in line with estimates on net income boost
- How is P&G’s CEO getting inflation-weary shoppers to pay more? It starts with cashmere-like diapers